Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02279654. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Post-authorization, Non-interventional, Safety Study Study of Patients With Myelodysplastic Syndromes (MDS) Treated With Lenalidomide.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This registry is a prospective, non-interventional, post authorisation safety study for patients diagnosed with Transfusion Dependent, IPSS low or intermediate-1-Risk Myelodysplastic Syndrome (MDS), associated to a single abnormality of the chromosome 5 \[del(5q)\]. The purpose of this study is to collect additional data about the safety of an oral drug (lenalidomide, Revlimid®) that may have been prescribed to relieve anemia and decrease the need of blood transfusions. However, also patients affected by the MDS del(5q) who receive other treatments different from lenalidomide can be included in this study, if they agree.
Study identification
- NCT ID
- NCT02279654
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 389 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 17, 2014 (Actual)
- Primary completion
- Mar 29, 2022 (Actual)
- Completion
- Mar 29, 2022 (Actual)
- Last update posted
- Aug 19, 2022
2014 – 2022
United States locations
- U.S. sites
- 13
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0001 | Centre City | New Jersey | ZIP CODE | — |
| Local Institution - 0002 | Centre City | New Jersey | ZIP CODE | — |
| Local Institution - Belgium | No City Provided | New Jersey | 00000 | — |
| Local Institution - Denmark | No City Provided | New Jersey | 00000 | — |
| Local Institution - France | No City Provided | New Jersey | 00000 | — |
| Local Institution - Germany | No City Provided | New Jersey | 00000 | — |
| Local Institution - Greece | No City Provided | New Jersey | 00000 | — |
| Local Institution - Italy | No City Provided | New Jersey | 00000 | — |
| Local Institution - Luxembourg | No City Provided | New Jersey | 00000 | — |
| Local Institution - Norway | No City Provided | New Jersey | 00000 | — |
| Local Institution - Spain | No City Provided | New Jersey | 00000 | — |
| Local Institution - Sweden | No City Provided | New Jersey | 00000 | — |
| Local Institution - UK | No City Provided | New Jersey | 00000 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 135 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02279654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2022 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.